OX-40: Life beyond the effector T cell stage

Seminars in Immunology

Volumn 10, Issue 6, 1998, Pages 471-480

  Weinberg, Andrew D ^a   Vella, Anthony T ^b   Croft, Michael ^c  

^a EARLE A CHILES RESEARCH INSTITUTE   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

CD4+ T cells; Disease; Effector function; Lymphokines; OX 40

Indexed keywords

ANTIBODY; AUTOANTIGEN; CD4 ANTIGEN; CELL SURFACE PROTEIN; IMMUNOTOXIN; INTERLEUKIN 2; MEMBRANE PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTATION; ARTICLE; CANCER; CELL DEATH; CENTRAL NERVOUS SYSTEM; EFFECTOR CELL; HUMAN; INFLAMMATION; MEMORY CELL; NONHUMAN; SURVIVAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0032394030     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1998.0146     Document Type: Article

References (31)

1. r detected only on CD4 positive T blasts. Molecular Immunol 24:1281-1289
2. 2. Mallett S, Fossum S, Barclay AN (1990) Characterization of the MRC OX-40 antigen of activated CD4 positive T lymphocytes - a molecule related to nerve growth factor receptor. EMBO 9(4):1063-1068
3. 3. Calderhead DM, Buhlman JE, van den Eertwegh AJM, Claassen E, Noelle RJ, Fell HP (1993) Cloning of mouse OX40: A T cell activation marker that may mediate T-B cell interactions. J Immunol 151:5261-5267
4. 4. Latza U, Durkop H, Schnittger S, Eitelbach F, Hummel M, Fonatcsh C, Stein H (1994) The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur J Immunol 24:677-682
5. 5. Baum PR, Gayle RB, Ramsdell F, Srinivasan S, Sorensen RA, Watson ML, Seldin MF, Baker E, Sutherland GR, Clifford KN, Alderson MR, Goodwin RG, Fanslow WC (1994) Molecular characterization of murine and human OX-40/OX-40 ligand systems: identification of a human OX-40 ligand as the HTLV-1-regulated protein gp34. EMBO 13(17): 3992-3998
6. 6. Weinberg AD, Wallin JJ, Jones RE, Sullivan U, Bourdette DN, Vandenbark AA, Offner H (1994) Target organ specific upregulation of the MRC OX-40 marker and selective production of Th1 lymphokine mRNA by encephalitogenic T helper cells isolated from the spinal cord of rats with experimental autoimmune encephalomyelitis. J Immunol 152:4712-4721
7. 7. Tittle TV, Weinberg AD, Steinkeler CN, Maziarz RT (1997) Expression of the T cell activation antigen, OX-40, identifies alloreactive T cells in acute Graft-Versus-Host Disease. Blood 89(12):4652-4658
8. 8. Vetto JT, Lum S, Morris A, Sicotte M, Davis J, Lemon M, Weinberg A (1997) Presence of the T cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head neck cancers. Am J Surg 174:258-265
9. 9. Weinberg AD, Sullivan TJ, Lemon M, Wallin JJ, Bourdette DN, Harmon RC, Fulton RJ, Offner H, Vandenbark AA (1996) Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Nature Med 2(2):183-189
10. 10. Gramaglia I, Lemon M, Weinberg AD, Croft M (1998) OX-40 Ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J Immunol (in press)
11. tax. Mol Cell Biol 11:1313-1319
12. + T cells with homology to tumor necrosis factor. J Exp Med 180:757-764
13. 13. Stuber E, Neurath M, Calderhead D, Fell HP, Strober W (1995) Crosslinking of OX-40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murin splenic B cells. Immunity 2:507-514
14. 14. Stuber E, Strober W (1996) The T cell-B cell interaction via OX-40 -OX-40L is necessary for the T cell-dependent humoral immune response. J Exp Med 183:979-992
15. 15. OhshimaY, Tanaka Y, Tozawa H, Takahashi Y, Maliszewski C, Delespesse G (1997) Expression and function of OX-40 ligand on human dendritic cells. J Immunol 159:3838-3848
16. 16. Imura A, Hori T, Imada K, Ishikawa T, Tanaka Y, Maeda M, Imamura S, Uchiyama T (1996) The human OX-40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med 183:2185-2191
17. 17. Weinberg AD, Wegmann KW, Funatake C, Whitham RH (1998) Blocking OX-40/OX40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of EAE. J Immunol (submitted)
18. + T cells. Int Immunol 10(4):453-461
19. + T cells in transgenic mice expressing a class II MHC restricted antigen receptor. Nature 341:746-748
20. 20. Zhang X, Brunner T, Carter L, Dutton RW, Rogers P, Bradley L, Sato T, Reed J, Green D, Swain (1997) Unequal death in T helper cell Th1 and Th2 effectors: Th1, but not Th2 effectors undergo rapid Fas:FasL mediated apoptosis. J Exp Med 185:1837-1849
21. 21. McCormack JE, Callahan JE, Kappler J, Marrack P (1993) Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol 150:3785-3792
22. 22. Vella AT, McCormack JE, Linsley PS, Kappler JW, Marrack P (1995) Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2:261-270
23. + T cells. J Immunol 159:591-598
24. + T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis. J Neurosci Res 43:42-49
25. 25. Gold DP, Offner H, Sun D, Wilery S, Vandenbark AA, Wilson DB (1991) Analysis of T cell receptor b chains in Lewis rats with EAE: conserved complementary region 3. J Exp Med 174:1476
26. + spinal cord T cells of Lewis rats with EAE. J Neurosci Res 44:562-567
27. 27. Buenafe AC, Tsu RC, Bebo B, Bakke AC, Vandenbark AA, Offner H (1997) A TCR Vα CDR3-specific motif associated with Lewis rat autoimmune encephalomyelitis and basic protein-specific T cell clones. J Immunol 158:5472-5483
28. 28. Tittle TV, Weinberg AD, Seelig FA, Godfrey WR, Engleman EG, Maziarz RT (1998) Expression of the human OX-40 receptor on T cells from patients with acute graft-versus-host disease. Bone Marrow Transplant (submitted)
29. 29. Weinberg AD (1998) Antibodies to OX-40 (CD134) can identify and eliminate autoreactive T cells: implications for human autoimmune disease. Molec Med Today 4(2):76-83
30. 30. Melero I, Shuford WW, Ashe S, Aruffo A, Ledbetter JA, Hellstrom KE, Mittler RS, Chen L (1997) Monoclonal antibodies against the 4-1BB T cell activation molecule eradicates established tumors. Nature Med 3(6):682-685
31. 31. Muy-Rivera M, Lemon M, Funatake C, Weinberg AD (1998) Enhancement of antitumor immunity by engaging the OX-40 receptor (CD134) in vivo. AACR meeting/New Orleans Abstract 3610:193